Pages 201 - 205
Genetic and pharmacological inactivation of cannabinoid CB1 receptor inhibits angiogenesis. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21460248/abstract/Genetic_and_pharmacological_ inactivation_of_cannabinoid_CB1_receptor_inhibits_angiogenesis_
Deficiency of type 1 cannabinoid receptors worsens acute heart failure induced by pressure overload in mice. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21785110
Cannabidiol as an anti-arrhythmic, the role of the CB1 receptors. (abst – 2011)
http://www.unboundmedicine.com/medline/ebm/record/22116907/abstract/17_Cannabidiol_as_an_anti_arr hythmic_the_role_of_the_CB1_receptors_
Regional changes in type 1 cannabinoid receptor availability in Parkinson's disease in vivo (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21459482/abstract/Regional_changes_in_type_1_c annabinoid_receptor_availability_in_Parkinson%27s_disease_in_vivo_
Cannabinoid Receptor Type 1 Protects Nigrostriatal Dopaminergic Neurons against MPTP Neurotoxicity by Inhibiting Microglial Activation. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22079984
Effects of cannabinoid CB(1) receptor agonism and antagonism on SKF81297-induced dyskinesia and haloperidol-induced dystonia in Cebus apella monkeys. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21029743
Early onset of aging-like changes is restricted to cognitive abilities and skin structure in Cnr1(-/-) mice. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/20724033
The G protein-coupled cannabinoid-1 (CB(1)) receptor of mammalian brain: Inhibition by phthalate esters in vitro. (abst - 2011) http://www.ncbi.nlm.nih.gov/pubmed/21763743
Residual effects of focal brain ischaemia upon cannabinoid CB(1) receptor density and functionality in female rats. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21145311
Alkamides and a neolignan from Echinacea purpurea roots and the interaction of alkamides with G-protein-coupled cannabinoid receptors. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21764086
Brain Type 1 Cannabinoid Receptor Availability in Patients with Anorexia and Bulimia Nervosa. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21718968
Increment of hypothalamic 2-arachidonoylglycerol induces the preference for a high-fat diet via activation of cannabinoid 1 receptors (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/20817042/abstract/Increment_of_hypothalamic_2_ arachidonoylglycerol_induces_the_preference_for_a_high_fat_diet_via_activation_of_cannabinoid_1_rece ptors_
201
Type I cannabinoid receptor trafficking: all roads lead to lysosome. (abst – 2011)
http://www.ncbi.nlm.nih.gov/pubmed/21040297
Intact cannabinoid CB1 receptors in the Alzheimer's disease cortex. (abst – 2011)
http://www.ncbi.nlm.nih.gov/pubmed/21034788
Endocannabinoid CB1 receptors modulate visual output from the thalamus. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21773721
Cannabinoids and emotionality: a neuroanatomical perspective. (abst – 2011)
http://www.ncbi.nlm.nih.gov/pubmed/21827834
The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors. (abst - 2011) http://www.ncbi.nlm.nih.gov/pubmed/21887137
Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22034972
Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21813113
α-Tocopherol and α-tocopheryl phosphate interact with the cannabinoid system in the rodent hippocampus. (abst - 2011) http://www.ncbi.nlm.nih.gov/pubmed/21843633
Interictal Type 1 Cannabinoid Receptor Binding is Increased in Female Migraine Patients. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22077199
Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [(18)F]MK-9470 PET. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/18077184
In vivo activation of endocannabinoid system in temporal lobe epilepsy with hippocampal sclerosis. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21303859
Cannabinoid Receptor Type 1 (CB1) Activation Inhibits Small GTPase RhoA Activity and Regulates Motility of Prostate Carcinoma Cells. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22087025
ENDOGENOUS CANNABINOID SYSTEM REGULATES INTESTINAL BARRIER FUNCTION IN VIVO THROUGH CANNABINOID TYPE 1 RECEPTOR ACTIVATION (abst – 2011)
http://ajpgi.physiology.org/content...i.00158.2011.abstract?sid=d420a7ad-54ba-4946- b1da-8bfe664eeec2
202
Impaired hippocampal glucoregulation in the cannabinoid CB(1) receptor knockout mice as revealed by an optimized in vitro experimental approach. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22155442
Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/22007164/abstract/Endocannabinoid_system_and_ psychiatry:_in_search_of_a_neurobiological_basis_for_detrimental_and_potential_therapeutic_effects_
Sexually dimorphic effects of cannabinoid compounds on emotion and cognition.
(abst - 2011) http://www.unboundmedicine.com/medline/ebm/record/21991251/abstract/Sexually_dimorphic_effects_of _cannabinoid_compounds_on_emotion_and_cognition_
CB1 receptors mediate rimonabant-induced pruritic responses in mice: investigation of locus of action. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21340468/abstract/CB1_receptors_mediate_rimon abant_induced_pruritic_responses_in_mice:_investigation_of_locus_of_action_
The cannabinoid type-1 receptor carboxyl-terminus, more than just a tail. (abst – 2011)
http://www.unboundmedicine.com/medline/ebm/record/21244428/abstract/The_cannabinoid_type_1_recep tor_carboxyl_terminus_more_than_just_a_tail_
Chronic Δ9-tetrahydrocannabinol treatment in rhesus monkeys: differential tolerance and cross-tolerance among cannabinoids. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21091643/abstract/Chronic_%CE%94%E2%81%B 9_tetrahydrocannabinol_treatment_in_rhesus_monkeys:_differential_tolerance_and_cross_tolerance_amon g_cannabinoids_
CB1 cannabinoid receptor mediates glucocorticoid effects on hormone secretion induced by volume and osmotic changes. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22211674
Endogenously generated 2-arachidonoylglycerol plays an inhibitory role in bombesin- induced activation of central adrenomedullary outflow in rats. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21371452
Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol. (full – 2011) http://onlinelibrary.wiley.com/doi/10.1002/biof.131/full
Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential. (abst – 2011)
http://www.unboundmedicine.com/medline/ebm/record/21513772/abstract/Association_between_a_cannab inoid_receptor_gene__CNR1__polymorphism_and_cannabinoid_induced_alterations_of_the_auditory_eve nt_related_P300_potential_
Intracellular Cannabinoid Type 1 (CB1) Receptors Are Activated by Anandamide
(abst – 2011)
http://www.jbc.org/content/286/33/29166.abstract?sid=2c3b88ec-b6e6-4245-a171-2e24c17b5e8b
203
Unbalance of CB1 receptors expressed in GABAergic and glutamatergic neurons in a transgenic mouse model of Huntington's disease. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22207189
Resorcinol-sn-Glycerol Derivatives: Novel 2-Arachidonoylglycerol Mimetics Endowed with High Affinity and Selectivity for Cannabinoid Type 1 Receptor. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22044209
The genetic basis of the endocannabinoid system and drug addiction in humans (abst – 2011) http://jop.sagepub.com/content/early/2011/09/20/0269881111416689
The G protein-coupled cannabinoid-1 (CB(1)) receptor of mammalian brain: Inhibition by phthalate esters in vitro. (abst - 2011) http://www.ncbi.nlm.nih.gov/pubmed/21763743
Upregulation of cannabinoid type 1 receptors in dopamine D2 receptor knockout mice is reversed by chronic forced ethanol consumption. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004984/?tool=pubmed
JWH-018 and JWH-073: {Delta}9-Tetrahydrocannabinol-Like Discriminative Stimulus Effects in Monkeys. (abst – 2012) http://www.unboundmedicine.com/medline/ebm/record/21965552/abstract/JWH_018_and_JWH_073:_%7 BDelta%7D9_Tetrahydrocannabinol_Like_Discriminative_Stimulus_Effects_in_Monkeys_
The inverse agonist effect of rimonabant on G protein activation is not mediated by the cannabinoid CB1 receptor: Evidence from postmortem human brain. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22093909
Cannabinoid Receptor Type 1 (CB1) Activation Inhibits Small GTPase RhoA Activity and Regulates Motility of Prostate Carcinoma Cells. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22087025
Dietary conditions and highly palatable food access alter rat cannabinoid receptor expression and binding density. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22005165
Opposing Roles for Cannabinoid Receptor Type-1 (CB(1)) and Transient Receptor Potential Vanilloid Type-1 Channel (TRPV1) on the Modulation of Panic-Like Responses in Rats. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/21937980
Extinction learning of rewards in the rat: is there a role for CB1 receptors? (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/21519986
Tolerance to cannabinoid-induced behaviors in mice treated chronically with ethanol. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/21701813
The cannabinoid receptor CB1 inverse agonist AM251 potentiates the anxiogenic activity
of urocortin I in the basolateral amygdala. (abst – 2012)
http://www.ncbi.nlm.nih.gov/pubmed/21736884
204
Cannabinoid Receptor Function is Altered by Nutrionally Deficient Diet (news – 2012)
http://www.examiner.com/medical-mar.../cannabinoid-receptor-function-is-altered-by- nutrionally-deficient-diet
CBR - CB2 CANNABINOID RECEPTOR - no "high", activated by THC, Anandamide, 2 -AG Cannabinoid Receptor Ligands (full - no date)
http://www.tocris.com/pdfs/cannabinoid_receptor_review/page_001.html
Cannabis and cannabinoids: pharmacology and rationale for clinical use (abst – 1999)
http://pharmgkb.org/pmid/10575283
Immunomodulation by Cannabinoids is Absent in Mice Deficient for the Cannabinoid Cb(2) Receptor. (abst – 2000) http://www.sciencedirect.com/science/article/pii/S0014299900002119
Involvement of central and peripheral cannabinoid receptors in the regulation of heart resistance to arrhythmogenic effects of epinephrine. (abst - 2000) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=11182823&dopt=abstrac tplus
Inhibition of Glioma Growth in Vivo by Selective Activation of the CB2 Cannabinoid Receptor1 (full - 2001) http://cancerres.aacrjournals.org/cgi/reprint/61/15/5784.pdf
Sourcing the Code: Searching for the Evolutionary Origins of Cannabinoid Receptors, Vanilloid Receptors, and Anandamide (full – 2002) http://www.cannabis-med.org/data/pdf/2002-01-3.pdf
Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease (full - 2002) http://bloodjournal.hematologylibra...ll/100/2/627?ijkey=eb71d6d7a06f311440761cfac6 a7d081bcc2771d
CB2 cannabinoid receptor agonists: pain relief without psychoactive effects? (abst - 2002) http://www.ncbi.nlm.nih.gov/pubmed/12550743
Lymphoma may be slowed by cannabis (news - 2002)
http://marijuana-ro.com/medical-usage/lymphoma-may-be-slowed-by-cannabis.html
Cannabinoid CB2 Receptors and Fatty Acid Amide Hydrolase Are Selectively Overexpressed in Neuritic Plaque-Associated Glia in Alzheimer's Disease Brains (full – 2003)
http://www.jneurosci.org/content/23/35/11136.full?maxtoshow=&hits=80&RESULTFORMAT=&fulltext= cannabinoid&searchid=1&FIRSTINDEX=80&resourcetype=HWCIT
205
Genetic and pharmacological inactivation of cannabinoid CB1 receptor inhibits angiogenesis. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21460248/abstract/Genetic_and_pharmacological_ inactivation_of_cannabinoid_CB1_receptor_inhibits_angiogenesis_
Deficiency of type 1 cannabinoid receptors worsens acute heart failure induced by pressure overload in mice. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21785110
Cannabidiol as an anti-arrhythmic, the role of the CB1 receptors. (abst – 2011)
http://www.unboundmedicine.com/medline/ebm/record/22116907/abstract/17_Cannabidiol_as_an_anti_arr hythmic_the_role_of_the_CB1_receptors_
Regional changes in type 1 cannabinoid receptor availability in Parkinson's disease in vivo (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21459482/abstract/Regional_changes_in_type_1_c annabinoid_receptor_availability_in_Parkinson%27s_disease_in_vivo_
Cannabinoid Receptor Type 1 Protects Nigrostriatal Dopaminergic Neurons against MPTP Neurotoxicity by Inhibiting Microglial Activation. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22079984
Effects of cannabinoid CB(1) receptor agonism and antagonism on SKF81297-induced dyskinesia and haloperidol-induced dystonia in Cebus apella monkeys. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21029743
Early onset of aging-like changes is restricted to cognitive abilities and skin structure in Cnr1(-/-) mice. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/20724033
The G protein-coupled cannabinoid-1 (CB(1)) receptor of mammalian brain: Inhibition by phthalate esters in vitro. (abst - 2011) http://www.ncbi.nlm.nih.gov/pubmed/21763743
Residual effects of focal brain ischaemia upon cannabinoid CB(1) receptor density and functionality in female rats. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21145311
Alkamides and a neolignan from Echinacea purpurea roots and the interaction of alkamides with G-protein-coupled cannabinoid receptors. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21764086
Brain Type 1 Cannabinoid Receptor Availability in Patients with Anorexia and Bulimia Nervosa. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21718968
Increment of hypothalamic 2-arachidonoylglycerol induces the preference for a high-fat diet via activation of cannabinoid 1 receptors (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/20817042/abstract/Increment_of_hypothalamic_2_ arachidonoylglycerol_induces_the_preference_for_a_high_fat_diet_via_activation_of_cannabinoid_1_rece ptors_
201
Type I cannabinoid receptor trafficking: all roads lead to lysosome. (abst – 2011)
http://www.ncbi.nlm.nih.gov/pubmed/21040297
Intact cannabinoid CB1 receptors in the Alzheimer's disease cortex. (abst – 2011)
http://www.ncbi.nlm.nih.gov/pubmed/21034788
Endocannabinoid CB1 receptors modulate visual output from the thalamus. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21773721
Cannabinoids and emotionality: a neuroanatomical perspective. (abst – 2011)
http://www.ncbi.nlm.nih.gov/pubmed/21827834
The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors. (abst - 2011) http://www.ncbi.nlm.nih.gov/pubmed/21887137
Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22034972
Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21813113
α-Tocopherol and α-tocopheryl phosphate interact with the cannabinoid system in the rodent hippocampus. (abst - 2011) http://www.ncbi.nlm.nih.gov/pubmed/21843633
Interictal Type 1 Cannabinoid Receptor Binding is Increased in Female Migraine Patients. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22077199
Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [(18)F]MK-9470 PET. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/18077184
In vivo activation of endocannabinoid system in temporal lobe epilepsy with hippocampal sclerosis. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21303859
Cannabinoid Receptor Type 1 (CB1) Activation Inhibits Small GTPase RhoA Activity and Regulates Motility of Prostate Carcinoma Cells. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22087025
ENDOGENOUS CANNABINOID SYSTEM REGULATES INTESTINAL BARRIER FUNCTION IN VIVO THROUGH CANNABINOID TYPE 1 RECEPTOR ACTIVATION (abst – 2011)
http://ajpgi.physiology.org/content...i.00158.2011.abstract?sid=d420a7ad-54ba-4946- b1da-8bfe664eeec2
202
Impaired hippocampal glucoregulation in the cannabinoid CB(1) receptor knockout mice as revealed by an optimized in vitro experimental approach. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22155442
Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/22007164/abstract/Endocannabinoid_system_and_ psychiatry:_in_search_of_a_neurobiological_basis_for_detrimental_and_potential_therapeutic_effects_
Sexually dimorphic effects of cannabinoid compounds on emotion and cognition.
(abst - 2011) http://www.unboundmedicine.com/medline/ebm/record/21991251/abstract/Sexually_dimorphic_effects_of _cannabinoid_compounds_on_emotion_and_cognition_
CB1 receptors mediate rimonabant-induced pruritic responses in mice: investigation of locus of action. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21340468/abstract/CB1_receptors_mediate_rimon abant_induced_pruritic_responses_in_mice:_investigation_of_locus_of_action_
The cannabinoid type-1 receptor carboxyl-terminus, more than just a tail. (abst – 2011)
http://www.unboundmedicine.com/medline/ebm/record/21244428/abstract/The_cannabinoid_type_1_recep tor_carboxyl_terminus_more_than_just_a_tail_
Chronic Δ9-tetrahydrocannabinol treatment in rhesus monkeys: differential tolerance and cross-tolerance among cannabinoids. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21091643/abstract/Chronic_%CE%94%E2%81%B 9_tetrahydrocannabinol_treatment_in_rhesus_monkeys:_differential_tolerance_and_cross_tolerance_amon g_cannabinoids_
CB1 cannabinoid receptor mediates glucocorticoid effects on hormone secretion induced by volume and osmotic changes. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22211674
Endogenously generated 2-arachidonoylglycerol plays an inhibitory role in bombesin- induced activation of central adrenomedullary outflow in rats. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21371452
Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol. (full – 2011) http://onlinelibrary.wiley.com/doi/10.1002/biof.131/full
Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential. (abst – 2011)
http://www.unboundmedicine.com/medline/ebm/record/21513772/abstract/Association_between_a_cannab inoid_receptor_gene__CNR1__polymorphism_and_cannabinoid_induced_alterations_of_the_auditory_eve nt_related_P300_potential_
Intracellular Cannabinoid Type 1 (CB1) Receptors Are Activated by Anandamide
(abst – 2011)
http://www.jbc.org/content/286/33/29166.abstract?sid=2c3b88ec-b6e6-4245-a171-2e24c17b5e8b
203
Unbalance of CB1 receptors expressed in GABAergic and glutamatergic neurons in a transgenic mouse model of Huntington's disease. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22207189
Resorcinol-sn-Glycerol Derivatives: Novel 2-Arachidonoylglycerol Mimetics Endowed with High Affinity and Selectivity for Cannabinoid Type 1 Receptor. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22044209
The genetic basis of the endocannabinoid system and drug addiction in humans (abst – 2011) http://jop.sagepub.com/content/early/2011/09/20/0269881111416689
The G protein-coupled cannabinoid-1 (CB(1)) receptor of mammalian brain: Inhibition by phthalate esters in vitro. (abst - 2011) http://www.ncbi.nlm.nih.gov/pubmed/21763743
Upregulation of cannabinoid type 1 receptors in dopamine D2 receptor knockout mice is reversed by chronic forced ethanol consumption. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004984/?tool=pubmed
JWH-018 and JWH-073: {Delta}9-Tetrahydrocannabinol-Like Discriminative Stimulus Effects in Monkeys. (abst – 2012) http://www.unboundmedicine.com/medline/ebm/record/21965552/abstract/JWH_018_and_JWH_073:_%7 BDelta%7D9_Tetrahydrocannabinol_Like_Discriminative_Stimulus_Effects_in_Monkeys_
The inverse agonist effect of rimonabant on G protein activation is not mediated by the cannabinoid CB1 receptor: Evidence from postmortem human brain. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22093909
Cannabinoid Receptor Type 1 (CB1) Activation Inhibits Small GTPase RhoA Activity and Regulates Motility of Prostate Carcinoma Cells. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22087025
Dietary conditions and highly palatable food access alter rat cannabinoid receptor expression and binding density. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22005165
Opposing Roles for Cannabinoid Receptor Type-1 (CB(1)) and Transient Receptor Potential Vanilloid Type-1 Channel (TRPV1) on the Modulation of Panic-Like Responses in Rats. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/21937980
Extinction learning of rewards in the rat: is there a role for CB1 receptors? (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/21519986
Tolerance to cannabinoid-induced behaviors in mice treated chronically with ethanol. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/21701813
The cannabinoid receptor CB1 inverse agonist AM251 potentiates the anxiogenic activity
of urocortin I in the basolateral amygdala. (abst – 2012)
http://www.ncbi.nlm.nih.gov/pubmed/21736884
204
Cannabinoid Receptor Function is Altered by Nutrionally Deficient Diet (news – 2012)
http://www.examiner.com/medical-mar.../cannabinoid-receptor-function-is-altered-by- nutrionally-deficient-diet
CBR - CB2 CANNABINOID RECEPTOR - no "high", activated by THC, Anandamide, 2 -AG Cannabinoid Receptor Ligands (full - no date)
http://www.tocris.com/pdfs/cannabinoid_receptor_review/page_001.html
Cannabis and cannabinoids: pharmacology and rationale for clinical use (abst – 1999)
http://pharmgkb.org/pmid/10575283
Immunomodulation by Cannabinoids is Absent in Mice Deficient for the Cannabinoid Cb(2) Receptor. (abst – 2000) http://www.sciencedirect.com/science/article/pii/S0014299900002119
Involvement of central and peripheral cannabinoid receptors in the regulation of heart resistance to arrhythmogenic effects of epinephrine. (abst - 2000) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=11182823&dopt=abstrac tplus
Inhibition of Glioma Growth in Vivo by Selective Activation of the CB2 Cannabinoid Receptor1 (full - 2001) http://cancerres.aacrjournals.org/cgi/reprint/61/15/5784.pdf
Sourcing the Code: Searching for the Evolutionary Origins of Cannabinoid Receptors, Vanilloid Receptors, and Anandamide (full – 2002) http://www.cannabis-med.org/data/pdf/2002-01-3.pdf
Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease (full - 2002) http://bloodjournal.hematologylibra...ll/100/2/627?ijkey=eb71d6d7a06f311440761cfac6 a7d081bcc2771d
CB2 cannabinoid receptor agonists: pain relief without psychoactive effects? (abst - 2002) http://www.ncbi.nlm.nih.gov/pubmed/12550743
Lymphoma may be slowed by cannabis (news - 2002)
http://marijuana-ro.com/medical-usage/lymphoma-may-be-slowed-by-cannabis.html
Cannabinoid CB2 Receptors and Fatty Acid Amide Hydrolase Are Selectively Overexpressed in Neuritic Plaque-Associated Glia in Alzheimer's Disease Brains (full – 2003)
http://www.jneurosci.org/content/23/35/11136.full?maxtoshow=&hits=80&RESULTFORMAT=&fulltext= cannabinoid&searchid=1&FIRSTINDEX=80&resourcetype=HWCIT
205